OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Posted on July 15, 2026

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Published: 2026-07-15T00:27:04+00:00